相似文献
1
Direct Cytosolic Delivery of CRISPR/Cas9-Ribonucleoprotein for Efficient Gene Editing.
ACS Nano. 2017 Mar 28;11(3):2452-2458. doi: 10.1021/acsnano.6b07600. Epub 2017 Jan 31.
2
Enhanced Cytosolic Delivery and Release of CRISPR/Cas9 by Black Phosphorus Nanosheets for Genome Editing.
Angew Chem Int Ed Engl. 2018 Aug 6;57(32):10268-10272. doi: 10.1002/anie.201806941. Epub 2018 Jul 13.
3
Delivering Cas9/sgRNA ribonucleoprotein (RNP) by lentiviral capsid-based bionanoparticles for efficient 'hit-and-run' genome editing.
Nucleic Acids Res. 2019 Sep 26;47(17):e99. doi: 10.1093/nar/gkz605.
4
Genome editing in potato via CRISPR-Cas9 ribonucleoprotein delivery.
Physiol Plant. 2018 Dec;164(4):378-384. doi: 10.1111/ppl.12731. Epub 2018 Apr 27.
5
Lipopeptide-Based Nanosome-Mediated Delivery of Hyperaccurate CRISPR/Cas9 Ribonucleoprotein for Gene Editing.
Small. 2019 Nov;15(46):e1903172. doi: 10.1002/smll.201903172. Epub 2019 Oct 7.
6
Scaffold-mediated non-viral delivery platform for CRISPR/Cas9-based genome editing.
Acta Biomater. 2019 May;90:60-70. doi: 10.1016/j.actbio.2019.04.020. Epub 2019 Apr 9.
7
Biomimetic Mineralization-Based CRISPR/Cas9 Ribonucleoprotein Nanoparticles for Gene Editing.
ACS Appl Mater Interfaces. 2019 Dec 26;11(51):47762-47770. doi: 10.1021/acsami.9b17598. Epub 2019 Dec 10.
8
Intracellular delivery and biodistribution study of CRISPR/Cas9 ribonucleoprotein loaded bioreducible lipidoid nanoparticles.
Biomater Sci. 2019 Jan 29;7(2):596-606. doi: 10.1039/c8bm00637g.
9
Rapid, Selection-Free, High-Efficiency Genome Editing in Protozoan Parasites Using CRISPR-Cas9 Ribonucleoproteins.
mBio. 2017 Nov 7;8(6):e01788-17. doi: 10.1128/mBio.01788-17.
10
Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing.
Theranostics. 2021 Jan 1;11(2):614-648. doi: 10.7150/thno.47007. eCollection 2021.
引用本文的文献
1
Agricultural biotechnology in China: product development, commercialization, and perspectives.
aBIOTECH. 2025 May 15;6(2):284-310. doi: 10.1007/s42994-025-00209-4. eCollection 2025 Jun.
2
Functionalized chitosan as nano-delivery platform for CRISPR-Cas9 in cancer treatment.
Asian J Pharm Sci. 2025 Jun;20(3):101041. doi: 10.1016/j.ajps.2025.101041. Epub 2025 Feb 26.
3
Unravelling fungal genome editing revolution: pathological and biotechnological application aspects.
Arch Microbiol. 2025 May 22;207(7):150. doi: 10.1007/s00203-025-04360-w.
4
Efficient Direct Cytosolic Protein Delivery via Protein-Linker Co-engineering.
ACS Appl Mater Interfaces. 2025 May 14;17(19):27858-27870. doi: 10.1021/acsami.5c02360. Epub 2025 Apr 30.
5
Precisely Targeted Nanoparticles for CRISPR-Cas9 Delivery in Clinical Applications.
Nanomaterials (Basel). 2025 Apr 2;15(7):540. doi: 10.3390/nano15070540.
6
Exploring Advanced CRISPR Delivery Technologies for Therapeutic Genome Editing.
Small Sci. 2024 Jul 25;4(10):2400192. doi: 10.1002/smsc.202400192. eCollection 2024 Oct.
7
Mechanistic Insights into the Tools for Intracellular Protein Delivery.
Chem Bio Eng. 2024 Dec 23;2(3):132-155. doi: 10.1021/cbe.4c00168. eCollection 2025 Mar 27.
8
Histidine-rich enantiomeric peptide coacervates enhance antigen sequestration and presentation to T cells.
Chem Sci. 2025 Mar 25;16(17):7523-7536. doi: 10.1039/d5sc01163a. eCollection 2025 Apr 30.
9
Efficient DNA- and virus-free engineering of cellular transcriptomic states using dCas9 ribonucleoprotein (dRNP) complexes.
Nucleic Acids Res. 2025 Mar 20;53(6). doi: 10.1093/nar/gkaf235.
10
Non-Invasive Delivery of CRISPR/Cas9 Ribonucleoproteins (Cas9 RNPs) into Cells via Nanoparticles for Membrane Transport.
Pharmaceutics. 2025 Feb 6;17(2):201. doi: 10.3390/pharmaceutics17020201.
本文引用的文献
1
Programmed Self-Assembly of Hierarchical Nanostructures through Protein-Nanoparticle Coengineering.
ACS Nano. 2017 Apr 25;11(4):3456-3462. doi: 10.1021/acsnano.6b07258. Epub 2017 Feb 28.
2
CRISPR-Cas9 gene editing: Delivery aspects and therapeutic potential.
J Control Release. 2016 Dec 28;244(Pt B):139-148. doi: 10.1016/j.jconrel.2016.08.002. Epub 2016 Aug 4.
3
Engineering Delivery Vehicles for Genome Editing.
Annu Rev Chem Biomol Eng. 2016 Jun 7;7:637-62. doi: 10.1146/annurev-chembioeng-080615-034711. Epub 2016 Apr 21.
4
CRISPR-Cas9 delivery to hard-to-transfect cells via membrane deformation.
Sci Adv. 2015 Aug 14;1(7):e1500454. doi: 10.1126/sciadv.1500454. eCollection 2015 Aug.
5
Efficient delivery of nuclease proteins for genome editing in human stem cells and primary cells.
Nat Protoc. 2015 Nov;10(11):1842-59. doi: 10.1038/nprot.2015.117. Epub 2015 Oct 22.
6
Cas9 gRNA engineering for genome editing, activation and repression.
Nat Methods. 2015 Nov;12(11):1051-4. doi: 10.1038/nmeth.3580. Epub 2015 Sep 7.
7
Self-assembled DNA nanoclews for the efficient delivery of CRISPR-Cas9 for genome editing.
Angew Chem Int Ed Engl. 2015 Oct 5;54(41):12029-33. doi: 10.1002/anie.201506030. Epub 2015 Aug 27.
8
Generation of knock-in primary human T cells using Cas9 ribonucleoproteins.
Proc Natl Acad Sci U S A. 2015 Aug 18;112(33):10437-42. doi: 10.1073/pnas.1512503112. Epub 2015 Jul 27.
9
Challenges in CRISPR/CAS9 Delivery: Potential Roles of Nonviral Vectors.
Hum Gene Ther. 2015 Jul;26(7):452-62. doi: 10.1089/hum.2015.069.
10
Therapeutic genome editing: prospects and challenges.
Nat Med. 2015 Feb;21(2):121-31. doi: 10.1038/nm.3793.
Zotero 插件